Skip to main content
SpringerLink
Log in

Steroid hormone activity of flavonoids and related compounds

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Soy isoflavones have been studied extensively for estrogenic and antiestrogenic properties. Other flavonoids, found in fruits, vegetables, tea and wine, have been much less tested for steroid hormone activity. We therefore assessed the estrogenic, androgenic and progestational activities of 72 flavonoids and structurally-related compounds. These compounds were tested on BT-474 human breast cancer cells at concentrations of 108–10−5 M, with estradiol (estrogen), norgestrel (progestin) and dihydrotestosterone (androgen) used as positive controls, and ethanol (solvent) as a negative control. pS2, an estrogen-regulated protein, and prostate-specific antigen (PSA), regulated by androgens and progestins, were quantified in tissue culture supernatants using ELISA-type immunofluorometric assays developed in-house. Of the 72 compounds tested, 18 showed estrogenic activity at 10−5 M. Of this subset, seven also showed progestational activity at this concentration. The soy isoflavones, biochanin A and genistein, showed the most potent estrogenic activity, with a dose-response effect up to 10−7 M. Of all other flavonoids, luteolin and naringenin displayed the strongest estrogenicity, while apigenin had a relatively strong progestational activity. Based on our data, we have formulated a set of structure/function relationships between the tested compounds. Flavonoids, therefore, exhibit significant steroid hormone activity, and may have an effect in the modification of cancer risk by diet, or in cancer therapeutics and prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang TT, Sathyamoorthy N, Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271–275, 1996

    Google Scholar 

  2. Hsieh CY, Santell RC, Haslam SZ, Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58: 3833–3838, 1998

    Google Scholar 

  3. Cassidy A, Bingham S, Setchell KD: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60: 333–340, 1994

    Google Scholar 

  4. Xu X, Duncan AM, Merz BE, Kurzer MS: Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 7: 1101–1108, 1998

    Google Scholar 

  5. Delmas PD: Clinical use of selective estrogen receptor modulators. Bone 25: 115–118, 1999

    Google Scholar 

  6. Weryha G, Pascal-Vigneron V, Klein M, Leclere J: Selective estrogen receptor modulators. Curr Opin Rheumatol 11: 301–306, 1999

    Google Scholar 

  7. Ansbacher R: Selective estrogen receptor modulators. Am J Obstet Gynecol 181: 1036, 1999

    Google Scholar 

  8. Hochner-Celnikier D: Pharmacokinetics of raloxifene and its clinical applications. Eur J Obstet Gynecol Reprod Biol 85: 23–29, 1999

    Google Scholar 

  9. Brzezinski A, Debi A: Phytoestrogens: the 'natural' selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 85: 47–51, 1999

    Google Scholar 

  10. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC: Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125: 384–389, 1996

    Google Scholar 

  11. Pillow PC, Duphorne CM, Chang S, Contois JH, Strom SS, Spitz MR, Hursting SD: Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer 33: 3–19, 1999

    Google Scholar 

  12. Noroozi M, Angerson WJ, Lean ME: Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 67: 1210–1218, 1998

    Google Scholar 

  13. Kuzumaki T, Kobayashi T, Ishikawa K: Genistein induces p21 (Cip1/WAF1) expression and blocks the Gl to S phase transition in mouse fibroblast and melanoma cells. Biochem Biophys Res Commun 251: 291–295, 1998

    Google Scholar 

  14. Constantinou AI, Kamath N, Murley JS: Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 34: 1927–1934, 1998

    Google Scholar 

  15. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57: 2916–2921, 1997

    Google Scholar 

  16. Hempstock J, Kavanagh JP, George NJ: Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. Br J Urol 82: 560–563, 1998

    Google Scholar 

  17. Fioravanti L, Cappelletti V, Miodini P, Ronchi E, Brivio M, Di Fronzo G: Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett 130: 143–152, 1998

    Google Scholar 

  18. Choi YH, Zhang L, Lee WH, Park KY: Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol 13: 391–396, 1998

    Google Scholar 

  19. McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS, Bundred NJ: Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 68: 1431S–1435S, 1998

    Google Scholar 

  20. Le Bail JC, Varnat F, Nicolas JC, Habrioux G: Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett 130: 209–216, 1998

    Google Scholar 

  21. Breinholt V, Larsen JC: Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 11: 622–629, 1998

    Google Scholar 

  22. Miksicek RJ: Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44: 37–43, 1993

    Google Scholar 

  23. Rosenberg RS, Grass L, Jenkins DJ, Kendall CW, Diamandis EP: Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochem Biophys Res Commun 248: 935–939, 1998

    Google Scholar 

  24. Miksicek RJ: Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 208: 44–50, 1995

    Google Scholar 

  25. Kitaoka M, Kadokawa H, Sugano M, Ichikawa K, Taki M, Takaishi S, Iijima Y, Tsutsumi S, Boriboon M, Akiyama T: Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med 64: 511–515, 1998

    Google Scholar 

  26. Hall RE, Lee CSL, Alexander IE, Shine J, Clarke CL, Sutherland RL: Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 46: 1081–1087, 1990

    Google Scholar 

  27. Rosenberg Zand RS, Jenkins DJ, Diamandis EP: Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2. J Clin Lab Anal 13: 241–245, 1999

    Google Scholar 

  28. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP: Ultrasensitive detection of prostate-specific antigen by a timeresolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 42: 675–684, 1996

    Google Scholar 

  29. Rio MC, Chambon P: The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer Cells 2: 269–274, 1990

    Google Scholar 

  30. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J: An androgen response element in a far upstream enhancer region is essential for high, androgenregulated activity of the prostate-specific antigen promoter. Mol Endocrinol 11: 148–161, 1997

    Google Scholar 

  31. Zarghami N, Grass L, Diamandis EP: Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 75: 579–588, 1997

    Google Scholar 

  32. Beato M, Truss M, Chavez S: Control of transcription by steroid hormones. Ann NY Acad Sci 784: 93–123, 1996

    Google Scholar 

  33. Yochum L, Kushi LH, Meyer K, Folsom AR: Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149: 943–949, 1999

    Google Scholar 

  34. Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E: Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10: 71–75, 1999

    Google Scholar 

  35. Hughes DA: Effects of dietary antioxidants on the immune function of middle-aged adults. Proc Nutr Soc 58: 79–84, 1999

    Google Scholar 

  36. Hassig A, Liang WX, Schwabl H, Stampfli K: Flavonoids and tannins: plant-based antioxidants with vitamin character. Med Hypotheses 52: 479–481, 1999

    Google Scholar 

  37. Critchfield JW, Butera ST, Folks TM: Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retroviruses 12: 39–46, 1996

    Google Scholar 

  38. Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD, West L: Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 84: 895–898, 1999

    Google Scholar 

  39. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D: The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 91: 6–11, 1998

    Google Scholar 

  40. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, et al.: Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381–386, 1995

    Google Scholar 

  41. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM: Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61: 2103–21l0.

  42. Renaud S, de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523–1526, 1992

    Google Scholar 

  43. Lean ME, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A: Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48: 176–18l, 1999

    Google Scholar 

  44. Lavy A, Fuhrman B, Markel A, Dankner G, Ben-Amotz A, Presser D, Aviram M: Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein. Ann Nutr Metab 38: 287–294, 1994

    Google Scholar 

  45. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD: Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer 33: 20–25, 1999

    Google Scholar 

  46. Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A: Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. Int J Oncol 14: 713–719, 1999

    Google Scholar 

  47. DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano MB, Hait WN, Gallo MA: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339: 785–791, 1998

    Google Scholar 

  48. Xu L, Glass CK, Rosenfeld MG: Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Gen Dev 9: 140–147, 1999

    Google Scholar 

  49. Lien BJ, Ren S, Bui HH, Wang R: Quantitative structureactivity relationship analysis of phenolic antioxidants. Free Radic Biol Med 26: 285–294, 1999

    Google Scholar 

  50. Ronco A, De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Leborgne F: Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer 35: 111–119, 1999

    Google Scholar 

  51. Cline JM, Hughes CL Jr: Phytochemicals for the prevention of breast and endometrial cancer. Cancer Treat Res 94: 107–134, 1998

    Google Scholar 

  52. Potter JD, Steinmetz K: Vegetables, fruit and phytoestrogens as preventive agents. IARC Sci Publ 139: 61–90, 1996

    Google Scholar 

  53. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN: Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146: 294–306, 1997

    Google Scholar 

Download references

Authors
  1. Rachel S. Rosenberg Zand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J.A. Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eleftherios P. Diamandis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zand, R.S.R., Jenkins, D.J. & Diamandis, E.P. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 62, 35–49 (2000). https://doi.org/10.1023/A:1006422302173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006422302173

Search

Navigation